Clinical utility of serum biomarkers in Duchenne muscular dystrophy

Assessments of disease progression and response to therapies in Duchenne muscular dystrophy (DMD) patients remain challenging. Current DMD patient assessments include complex physical tests and invasive procedures such as muscle biopsies, which are not suitable for young children. Defining alternati...

Descripción completa

Detalles Bibliográficos
Autores principales: Hathout, Yetrib, Seol, Haeri, Han, Meng Hsuan J., Zhang, Aiping, Brown, Kristy J., Hoffman, Eric P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4820909/
https://www.ncbi.nlm.nih.gov/pubmed/27051355
http://dx.doi.org/10.1186/s12014-016-9109-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4820909/
https://www.ncbi.nlm.nih.gov/pubmed/27051355
http://dx.doi.org/10.1186/s12014-016-9109-x

Ejemplares similares